Skip to main content
OpenTrials

Clinical trial condition

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

294 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Recruiting

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05745714

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details
Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

NCT05658640

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 36 locations
View Trial Details
Recruiting

HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

NCT05751044

Conditions
Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • St. Anna Kinderspital Vienna, Austria
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Rigshospitalet Copenhagen Copenhagen, Denmark
  • Helsinki University Hospital, New Children's Hospital Helsinki, Finland
View all 33 locations
View Trial Details
Recruiting

Newly-diagnosed Pediatric T-cell ALL Protocol

NCT06855810

Conditions
Acute Lymphoblastic Leukemia, Childhood Leukemia, Acute Lymphoblastic, Hematologic Diseases, +12 more
Locations
  • Anhui Medical University Second Affiliated Hospital Hefei, Anhui, China
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Chongqing Medical University Affiliated Children's Hospital Chongqing, Chongqing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
View all 27 locations
View Trial Details
Recruiting

Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

NCT04315324

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • PCR Oncology Arroyo Grande, California, United States
View all 163 locations
View Trial Details

Related conditions